These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24752265)

  • 21. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States.
    Johnson JR; Johnston B; Clabots C; Kuskowski MA; Castanheira M
    Clin Infect Dis; 2010 Aug; 51(3):286-94. PubMed ID: 20572763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli.
    Johnson JR; Johnston B; Kuskowski MA; Sokurenko EV; Tchesnokova V
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4471-80. PubMed ID: 25987621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic.
    Matsumura Y; Johnson JR; Yamamoto M; Nagao M; Tanaka M; Takakura S; Ichiyama S; ;
    J Antimicrob Chemother; 2015; 70(6):1639-49. PubMed ID: 25687644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009.
    Johnson JR; Urban C; Weissman SJ; Jorgensen JH; Lewis JS; Hansen G; Edelstein PH; Robicsek A; Cleary T; Adachi J; Paterson D; Quinn J; Hanson ND; Johnston BD; Clabots C; Kuskowski MA;
    Antimicrob Agents Chemother; 2012 May; 56(5):2364-70. PubMed ID: 22354301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extraintestinal pathogenic Escherichia coli sequence type 131 H30-R and H30-Rx subclones in retail chicken meat, Italy.
    Ghodousi A; Bonura C; Di Carlo P; van Leeuwen WB; Mammina C
    Int J Food Microbiol; 2016 Jul; 228():10-3. PubMed ID: 27082892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics.
    Blanco J; Mora A; Mamani R; López C; Blanco M; Dahbi G; Herrera A; Marzoa J; Fernández V; de la Cruz F; Martínez-Martínez L; Alonso MP; Nicolas-Chanoine MH; Johnson JR; Johnston B; López-Cerero L; Pascual A; Rodríguez-Baño J;
    J Clin Microbiol; 2013 Oct; 51(10):3358-67. PubMed ID: 23926164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G; Costello M; Pitout JD
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular epidemiology and virulence of Escherichia coli O16:H5-ST131: comparison with H30 and H30-Rx subclones of O25b:H4-ST131.
    Dahbi G; Mora A; Mamani R; López C; Alonso MP; Marzoa J; Blanco M; Herrera A; Viso S; García-Garrote F; Tchesnokova V; Billig M; de la Cruz F; de Toro M; González-López JJ; Prats G; Chaves F; Martínez-Martínez L; López-Cerezo L; Denamur E; Blanco J
    Int J Med Microbiol; 2014 Nov; 304(8):1247-57. PubMed ID: 25455219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of infections caused by extended-spectrum β-lactamase-producing Escherichia coli from community hospitals in South Africa.
    Peirano G; van Greune CH; Pitout JD
    Diagn Microbiol Infect Dis; 2011 Apr; 69(4):449-53. PubMed ID: 21396544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and characteristics of ST131 clone among unselected clinical
    Li B; Lu Y; Lan F; He Q; Li C; Cao Y
    Antimicrob Resist Infect Control; 2017; 6():118. PubMed ID: 29167743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of virulence determinants among Escherichia coli ST131 and its H30/H30-Rx subclones in Turkey.
    Er DK; Dündar D; Uzuner H
    Acta Microbiol Immunol Hung; 2023 Mar; 70(1):47-51. PubMed ID: 36459132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole genome sequencing, molecular typing and in vivo virulence of OXA-48-producing Escherichia coli isolates including ST131 H30-Rx, H22 and H41 subclones.
    de Toro M; Fernández J; García V; Mora A; Blanco J; de la Cruz F; Rodicio MR
    Sci Rep; 2017 Sep; 7(1):12103. PubMed ID: 28935873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ST131 Escherichia coli H22 subclone from human intestinal microbiota: Comparison of genomic and phenotypic traits with those of the globally successful H30 subclone.
    Nicolas-Chanoine MH; Petitjean M; Mora A; Mayer N; Lavigne JP; Boulet O; Leflon-Guibout V; Blanco J; Hocquet D
    BMC Microbiol; 2017 Mar; 17(1):71. PubMed ID: 28347271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China.
    Zhong YM; Liu WE; Liang XH; Li YM; Jian ZJ; Hawkey PM
    J Antimicrob Chemother; 2015 Aug; 70(8):2223-7. PubMed ID: 25957581
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Johnson JR; Johnston B; Thuras P; Launer B; Sokurenko EV; Miller LG
    mSphere; 2016; 1(6):. PubMed ID: 27904884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different Escherichia coli B2-ST131 clades (B and C) producing extended-spectrum β-lactamases (ESBL) colonizing residents of Portuguese nursing homes.
    Rodrigues C; Machado E; Fernandes S; Peixe L; Novais Â
    Epidemiol Infect; 2017 Nov; 145(15):3303-3306. PubMed ID: 29039274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan.
    Yokota S; Sato T; Okubo T; Ohkoshi Y; Okabayashi T; Kuwahara O; Tamura Y; Fujii N
    Chemotherapy; 2012; 58(1):52-9. PubMed ID: 22343392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648.
    Sherchan JB; Hayakawa K; Miyoshi-Akiyama T; Ohmagari N; Kirikae T; Nagamatsu M; Tojo M; Ohara H; Sherchand JB; Tandukar S
    Antimicrob Agents Chemother; 2015; 59(6):3424-32. PubMed ID: 25824221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum β-lactamase-producing E. coli in Japan.
    Matsumura Y; Yamamoto M; Higuchi T; Komori T; Tsuboi F; Hayashi A; Sugimoto Y; Hotta G; Matsushima A; Nagao M; Takakura S; Ichiyama S
    Int J Antimicrob Agents; 2012 Aug; 40(2):158-62. PubMed ID: 22743014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular epidemiology of bloodstream-associated
    Can F; Kurt-Azap O; Nurtop E; Ispir P; Seref C; Ergonul O
    J Med Microbiol; 2016 Apr; 65(4):306-310. PubMed ID: 26795934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.